Immuno-Oncology Summit Boston 2027

Who sponsors ImmunoMark

Built for companies that sell to oncology R&D teams

Our London 2026 sponsors came from five kinds of company, and the Biomarkers & CDx stream adds a sixth. If yours is on this list, the agenda is built around your buyers.

Biomarker and lab services

Biomarker testing, flow cytometry and assay services for clinical trials.

Who you meet: Translational medicine and clinical biomarker leads

Preclinical models and discovery

In vivo models and antibody discovery for immuno-oncology pipelines.

Who you meet: Discovery, pharmacology and preclinical heads

Cell analysis and proteomics platforms

Instruments, reagents and platforms for immune profiling and proteomics.

Who you meet: Immune monitoring and translational science teams

Spatial biology and tissue analysis

Functional and spatial readouts from patient tissue.

Who you meet: Pathology and biomarker discovery leads

Research data and AI

Data, literature and analytics for R&D and competitive intelligence.

Who you meet: R&D strategy and data science teams

Diagnostics and CDx developers

The Biomarkers & CDx stream covers CDx development, regulatory strategy and market access.

Who you meet: Pharma CDx, regulatory and medical diagnostics leads

Stream 2: Biomarkers & Companion Diagnostics

Tell us which roles you need to meet and we will show you how the audience matches up.

Request the prospectus

East Coast launch edition

Why sponsor an immuno-oncology summit in Boston

ImmunoMark Boston is an immuno-oncology conference in Boston for companies that sell into IO programs: research tools, immune monitoring, cell therapy manufacturing and translational services. The East Coast launch edition runs in June 2027, with Stream 1 dedicated to Immuno-Oncology and a parallel Stream 2 on Biomarkers & Companion Diagnostics.

Boston and Cambridge are home to one of the world’s densest concentrations of biotech companies, academic medical centers and cancer research institutes. For an IO vendor, that means many of the program teams you want to reach are already a short trip from the venue. The question is not whether those buyers exist, but how to get twenty focused minutes with the right ones. That is what this event is built to do.

The format is the one proven at London 2026: keynotes, panels and case studies across two parallel streams, a drinks reception at the end of Day 1, and pre-scheduled 20-minute 1:1 meetings chosen from the full delegate list and profiles, which reach sponsors about 10 days before the event.

300+industry-focused delegates expected in Boston

20 minper pre-scheduled 1:1 meeting

15–25meetings per sponsor at London 2026

70%senior decision-makers at London 2026

Functions on the faculty

Who buys IO tools and services, and what each function needs from you

The Boston Stream 1 speaker panel spans discovery, translational, computational and regulatory roles. Each one weighs a vendor against a different question.

Function on the Boston faculty	What that function looks for in an IO vendor
Scientific Director, Precision Medicine Oncology, AbbVie	Assays and immune profiling that can follow a molecule from first-in-human studies into patient selection
Associate Scientist, Obsidian Therapeutics	Analytical methods that characterize engineered cell products and track their persistence in patients
Computational Science Lead, Sanofi	Data quality, standardized outputs and pipelines that slot into existing analysis workflows
Director, Global Regulatory Affairs, Oncology, AstraZeneca	Validated methods and documentation that will hold up in an IND or a marketing application
Instructor in Medical Oncology, Dana-Farber Cancer Institute	Clinical feasibility: sample logistics, turnaround and what a trial site can realistically support

The faculty shows which functions will be in the room; it is not a list of guaranteed meetings. Your 1:1s are chosen from the full delegate list, so you can target the same functions at every company that comes. The Boston agenda’s audience profile is 55–60% pharmaceutical and biotech companies, 10–15% academic and research institutions, 5–10% hospitals, cancer centers and CROs, and 5% government, regulatory and industry organizations.

Real Stream 1 sessions

IO conference Boston 2027: the sessions your buyers will sit through

Stream 1 moves from first-in-class targets through translational modeling to resistance and the pipeline outlook. Each session gives you a natural opening line for a meeting later that day.

Day 1 · Stream 1Novel Immune Checkpoints and First-in-Class IO Assets
Day 1 · Stream 1Subcutaneous Delivery of Biologics and Other Modalities: Unlocking Efficacy, Safety, and Patient-Centricity Beyond IV (Manuel Sanchez-Felix, Principal & Founder, Sanchez-Felix Drug Delivery Consultancy LLC, and Interim Chief Scientific Officer, Pendant Biosciences)
Day 1 · Stream 1Bispecific & Multispecific Immune Engagers
Day 1 · Stream 1From Data to Decisions: The Role of Translational Modeling in Modern Drug Development (Niharika Gummaraj Srinivas, Clinical Pharmacology and Pharmacometrics Postdoc Fellow, Gilead Sciences)
Day 1 · Stream 1Translational Models Supporting IND Readiness
Day 1 · Stream 1Lessons from Pivotal US IO Trials
Day 2 · Stream 1Keynote: The Future of Immunotherapy in the US Market
Day 2 · Stream 1Neoadjuvant & Adjuvant Immunotherapy
Day 2 · Stream 1Innovative Clinical Trial Designs in IO
Day 2 · Stream 1Mechanisms of Resistance to Immunotherapy
Day 2 · Stream 1Immuno-Oncology in 2030: Pipeline Outlook

Cell therapy vendors should also note a Day 1 Stream 2 session in the next room: Biomarker Assays, Immune Profiling, CAR-T, TCR-T, and NK Cell Therapies for Solid Tumors or Analytical Strategies Supporting Cell Therapies (Priyanka Joshi, Associate Scientist, Obsidian Therapeutics). That overlap is why this works as a cancer immunotherapy conference in Boston for CDMOs, CROs and immune monitoring labs alike: the therapy teams and the people who measure what their therapies do share one floor. For a sense of who is building IO pipelines locally, see our guide to Boston oncology biotech companies.

Fit by vendor type

How each IO vendor type plays an immunotherapy conference in Boston in 2027

The same two days work differently depending on what you sell. Plan your meetings around the sessions that match your offer.

IO research tools and reagentsAnchor your pitch on the first-in-class assets and bispecific sessions on Day 1, then use meetings with discovery and translational scientists to discuss target validation and screening.
Immune monitoring and profiling labsThe Day 2 resistance and trial design sessions frame the question every IO trial sponsor asks: who responds, and why? Bring examples of longitudinal immune readouts.
Cell therapy CDMOs and analytical service providersTarget translational and process roles. The Day 1 IND readiness and cell therapy analytics sessions put potency, characterization and comparability on the table.
Translational CROs and modeling groupsThe translational modeling and pivotal US trials sessions draw clinical pharmacology, biostatistics and development strategy teams: the people who commission translational work.
Every vendor: follow up the same eveningUse the Day 1 drinks reception to continue conversations from the morning, and keep Day 2 meetings for the people who asked for data.

Estimate what a set of pre-scheduled IO meetings is worth to your pipeline before you choose a package.

Run the ROI calculator

Package fit

Which packages fit IO tools, cell therapy and translational service companies

The Boston agenda reserves three Platinum talk slots per stream on Day 1, three Gold slots per stream on Day 2 before lunch and three Silver slots per stream after lunch. Deciding early gives IO companies more time to plan their meetings and talk.

Best fit

Platinum (Stream 1)

Stage time on Day 1, alongside the bispecific, translational modeling and IND readiness sessions, plus enough meetings to follow up with the people who heard you.

30-minute Day 1 talk plus Q&A in Stream 1
10 pre-scheduled 1:1 meetings
10 x 6 ft booth and a banner in the conference room
8 delegate + 8 client passes
Email campaign and a 1-minute video promotion

Headline

Exclusive to one company. The only package that speaks to both streams, for vendors who sell to IO program teams and biomarker teams at once.

5-minute welcome speech and a 30-minute Day 1 morning keynote across both streams
15 pre-scheduled 1:1 meetings
20 x 12 ft exhibition space
10 delegate + 10 client passes
“Powered by” branding and an email to the full pre-qualified database

Exclusive 1:1 Meetings

Meetings without a booth or talk: a practical way to test the Boston market at a launch edition.

3, 5, 7 or 10 pre-arranged 20-minute meetings
2–4 delegate passes, plus drinks reception passes
Wishlist and delegate list with contact details
Logo and company description in the brochure and on the webpage

Full tier details are on the Boston sponsorship opportunities page, and the exclusive position is explained on the Boston headline sponsor page. Selling into the Stream 2 side too? See the Boston biomarker conference and Boston companion diagnostics conference pages. To compare editions, read the San Diego cancer immunotherapy conference page and the immuno-oncology summit series overview.

Tell us which IO functions you want to meet and we will recommend the right Stream 1 package.

Request the prospectus

Sponsorship ROI calculator

What could Boston 2027 be worth to your team?

Pick a package, add your own numbers and see the pipeline it creates. London 2026 sponsors averaged 15 to 25 meetings each, with 70% senior decision-makers in the room.

1. Choose a package

Sponsorship packages

Exclusive 1:1 meeting packages

2. Your numbers

Average first-year deal value

Year-one value of a new pharma or biotech customer

Extra conversations at the event

Booth visits, networking and questions after your talk

Become a real opportunity

Share of conversations worth a proposal

Opportunities you usually win

Your typical close rate

Your total event budget

Sponsorship plus travel and team costs

Estimated return

expected first-year revenue for every $1 of your event budget

Pre-scheduled 1:1 meetings

Qualified conversations

New opportunities

Cost per conversation

Pipeline created

Expected revenue won

Get pricing and the prospectus for this package

Talk to our team

Estimates only, based on the numbers you enter. Meetings and inclusions from the Boston 2027 sponsorship prospectus. 1:1 meetings are pre-scheduled with delegates you choose from the attendee list.

Email me this estimate

We will send your numbers to your inbox, ready to share with your team. Our sponsorship team gets a copy so they can answer questions.

What sponsors said

Feedback from London 2026 sponsors

Here is what sponsors told us at our London 2026 launch edition.

We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.

Project Manager

PromoCell GmbH · Sponsor, London 2026

We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.

BD Manager Europe

Secretech · Sponsor, London 2026

Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.

Research Account Manager

Miltenyi Biotec · Sponsor, London 2026

My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.

Senior Business Development Director Europe

Rouken Bio · Sponsor, London 2026

We got the occasion to discuss customer projects and understand their needs better and how we can help them.

Epigenomics Applications Specialist

Hologic Diagenode · Sponsor, London 2026

The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.

Biopharma Business Development Manager EMEA

Hologic Diagenode · Sponsor, London 2026

Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.

Business Development Executive

HistologiX · Sponsor, London 2026

The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.

Product Specialist

HAWK Biosystems · Sponsor, London 2026

Get the prospectus

Frequently asked questions

Is ImmunoMark Boston an immuno-oncology conference or a biomarker event?

Both. Stream 1 is dedicated to Immuno-Oncology, covering next-generation checkpoints, cell therapies for solid tumors, bispecific engagers, resistance and translational models. Stream 2 runs in parallel on Biomarkers & Companion Diagnostics. Your 1:1 meetings draw on the full delegate list across both streams.

When and where is the Boston edition?

The East Coast launch edition takes place in Boston in June 2027. Exact dates and the venue will be confirmed by the sponsorship team. It follows the San Diego edition (10–11 February 2027) and the London edition (3–4 March 2027).

We are a cell therapy CDMO. Who will we be able to meet?

The Boston Stream 1 faculty includes translational, computational, regulatory and clinical roles from companies such as AbbVie, Sanofi, AstraZeneca and Obsidian Therapeutics, and the agenda includes Translational Models Supporting IND Readiness. Meetings are chosen by you from the full delegate list and profiles, sent about 10 days before the event.

Can we give a talk in Stream 1?

Yes. Platinum sponsors get a 30-minute Day 1 talk, Gold sponsors a 30-minute Day 2 pre-lunch talk and Silver sponsors a 15-minute Day 2 post-lunch talk, each in the stream you choose. The Headline sponsor gives a Day 1 morning keynote across both streams.

What results did sponsors see at the previous edition?

Boston is a launch edition, so the track record comes from London 2026: 300+ delegates from 100+ companies, 70% senior decision-makers, 200+ meetings, 15–25 meetings per sponsor and 55+ pre-scheduled 1:1s for title sponsors. Boston uses the same meeting model.

Immuno-Oncology Conference Boston: Meet IO Program Teams 1:1

Get the prospectus and package availability